These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8336641)

  • 1. Desogestrel--a new progestin for oral contraception.
    Med Lett Drugs Ther; 1993 Aug; 35(902):73-4. PubMed ID: 8336641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Novynette--trends in contraception at the beginning of the new millennium].
    Ivanov S; Sigridov I
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():30-2. PubMed ID: 15518273
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of the monophase oral contraceptive combination with 20 ug ethinyl estradiol/150 ug desogestrel on haemostasis].
    Uchikova E; Milchev N; Terzhumanov R; Markova D
    Akush Ginekol (Sofiia); 2004; 43(4):29-32. PubMed ID: 15318540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mircette: a novel oral contraceptive. Introduction.
    Speroff L
    Am J Obstet Gynecol; 1998 Jul; 179(1):S1. PubMed ID: 9704811
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise-induced fibrin formation is enhanced in women using third-generation oral contraceptives.
    Walter B; Weiss C; Dorsch M; Bärtsch P
    J Thromb Haemost; 2006 Apr; 4(4):898-9. PubMed ID: 16634763
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of low-dose oral contraceptive regulon-Gedeon Richter on some hemostatic variables].
    Uchikova E; Ledzhev I; Milchev N; Tsvetkova T
    Akush Ginekol (Sofiia); 2004; 43(2):58-62. PubMed ID: 15185533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of the low dose oral contraceptive novynette].
    Uchikova E; Milchev N
    Akush Ginekol (Sofiia); 2003; 42(4):15-6. PubMed ID: 14577362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
    Vree ML; Schmidt J
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-generation oral contraceptives and low free protein S as a risk for venous thrombosis.
    Villa P; Aznar J; Mira Y; Fernández MA; Vayá A
    Lancet; 1996 Feb; 347(8998):397. PubMed ID: 8598720
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Axillary vein thrombosis in a young woman with a contraceptive ring. Prothrombin gene mutation a possible connection].
    Samuelsson E; Hultdin J; Groth K; Hedenmalm K
    Lakartidningen; 2007 Jan 10-16; 104(1-2):32-4. PubMed ID: 17323737
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renewed interest in haemostasis changes induced by oral contraceptives (OCs).
    Kluft C
    Thromb Haemost; 2000 Jul; 84(1):1-3. PubMed ID: 10928460
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.
    Kluft C; Endrikat J; Mulder SM; Gerlinger C; Heithecker R
    Contraception; 2006 Apr; 73(4):336-43. PubMed ID: 16531162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower- vs higher-dose estrogen for contraception.
    Kripke C
    Am Fam Physician; 2005 Oct; 72(7):1224-5. PubMed ID: 16229072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.